2,177 drugs to review in 2008.

Published: 2006-01-19 06:58:00

Updated: 2006-01-19 06:58:00

The drug review plans in 2008 selected the total 2,177 drugs in 29 different therapeutic groups including 1,884 herbal preparations and disclosed in far advance so that the relevant drug companies should prepare required data according to the related provisions, stipulating such advanced disclosu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK